Monthly Pharma News Review of PharmaSources (February) - Chinese Drug review and approval
The anti-PD-L1 monoclonal antibody Adebrelimab from Hengrui Pharmaceuticals was approved for marketing, and the Class 3 chemotherapy Limaprost tablets from Sino Biopharm were approved for marketing.
March 14, 2023
by Caicai/PharmaSources
Weekly Pharma News Review | PharmaSources.com (Feb.6th - 10th, 2023)
A new indication of Pfizer's tofacitinib sustained release tablet was approved in China; Phase III study of obesity indication of Eli Lilly's Tirzepatide succeeded in China.
February 13, 2023
by Caicai
Weekly Pharma News Review | PharmaSources.com (1114-1118)
The news review of this week is from November 14 to 18, covering a total of 23 pieces of information in 3 sections, i.e., drug review, R&D, and business.
November 21, 2022
by PharmaSources.com
Weekly Pharma News Review | PharmaSources.com (1107-1111)
The news review of this week is from November 7 to 11, covering a total of 26 pieces of information in 3 sections, i.e., drug review, R&D, and business.
November 14, 2022
by PharmaSources.com
Weekly Pharma News Review | PharmaSources.com (1031-1104)
The news review of this week is from October 31 to November 4, covering a total of 25 pieces of information in 3 sections, i.e., drug review, R&D, and business.
November 8, 2022
by PharmaSources.com
Weekly Pharma News Review | PharmaSources.com (1024-1028)
The news review of this week is from October 24 to 28, covering a total of 23 pieces of information in 4 sections, i.e., drug review, R&D, business and listing.
October 31, 2022
by PharmaSources.com
Weekly Pharma News Review | PharmaSources.com (1017-1021)
The news review of this week is from October 17 to 21, covering a total of 21 pieces of information in 3 sections, i.e., drug review, R&D, and listing.
October 24, 2022
by PharmaSources.com
Weekly Pharma News Review | PharmaSources.com (1008-1014)
The most exciting thing for the industry is the first-in-class drug, Dorzagliatin Tablets, which is independently researched and developed by Hua Medicine was approved for marketing, becoming the first approved new drug for GKA diabetes in the world.
October 18, 2022
by PharmaSources.com
Weekly Pharma News Review | PharmaSources.com (0926-0930)
The news reviewed this week is from September 26 to 30, covering a total of 26 pieces of information in 4 sections, i.e. drug review, R&D, business and policy.
October 8, 2022
by PharmaSources.com
Weekly Pharma News Review | PharmaSources.com (0919-0923)
The news reviewed this week is from September 19 to 23, covering a total of 25 pieces of information in 4 sections, i.e. drug review, R&D, and business and listing.
September 26, 2022
by PharmaSources.com
Weekly Pharma News Review | PharmaSources.com (0912-0916)
The news reviewed this week is from September 12 to 16, covering a total of 26 pieces of information in 3 sections, i.e., drug review, R&D, and business.
September 20, 2022
by PharmaSources.com
Weekly Pharma News Review | PharmaSources.com (0905-0909)
The news review of this week is from September 5 to 9, covering a total of 25 pieces of information in 3 sections, i.e., drug review, R&D, and business.
September 14, 2022
by PharmaSources.com